1.Atopic Dermatitis. Withdrawal from Steroid and Effect of Sekko.
Jiro FUJIWARA ; Midori FUKUDA ; Yoshiko INOUE ; Yoshiko SAITO
Kampo Medicine 2002;52(4-5):507-514
Treating atopic dermatitis patients, who have used steroid, only through Chinese herb medication, it often happens that extract medicine doesn't work well and infusion one is needed.
We treat with Seiun-haidoku-in-kagen “Ekisin-ittoku” and its amount, to stop using steroid, often exceeds as twice or three times much as ordinary use. Especially Sekko needs large quantities, 40-100g a day for adults to get out of steroid.
In early treatments, some patients couldn't stop applying steroid because of insufficient increase of Sekko, but after increasing its amount until it have effects, they all have got out of steroid.
It is effective to take herb-medicated bath and some original ointment at the same time. We report on the case in which one can withdraw from steroid by these treatments.
2.Difficulties in Home-Visit Rehabilitation for Elderly Foreign Residents: Interviews with Physical Therapists
Journal of International Health 2023;38(2):53-64
Introduction With the increase in the number of foreign residents in Japan and the aging of the population, it is expected that there will be more opportunities to provide home-visit rehabilitation to foreign residents are increasing. The purpose of this study was to clarify the difficulties that physical therapists (PTs) face when providing home-visit rehabilitation to elderly foreign residents.Methods A qualitative descriptive study using semi-structured interviews was conducted with PTs who have experience in providing home-visit rehabilitation to elderly foreign residents.Results The subjects were 11 PTs (9 males and 2 females), with an average age of 39.3 years and the average years of PT experience 13.7 years. The analysis revealed that the difficulties faced by PTs included 10 categories; [Differences in rehabilitation concepts with foreign elderly], [Difficulty in goal setting], [Lack of multilingual support and access to information on support], [Burden of dealing with non-rehabilitation work], [Building trust through daily communication], [Detailed communication in different languages], [Dealing with cultural differences], [Differences in religion and sensitivity to this topic], [Dealing with elderly foreign residents who are hesitant to contact with Japanese people] and [Anxiety about conducting home-visit rehabilitation due to PT’s preconceived notions about foreigners].Conclusions Differences in the rehabilitation concepts between Japan and some foreign countries were found as a difficulty faced by PTs. Difficulties due to language differences were significant, and institutional difficulties also existed, such as lack of multilingual support and access to information on support. In addition, by visiting private homes and providing individualized services, PTs sometimes had to deal with problems faced by elderly foreign people other than rehabilitation work. These were considered to make it difficult to implement goal-oriented rehabilitation.
3.Pranlukast reduces asthma exacerbations during autumn especially in 1- to 5-year-old boys
Yoshinori MORITA ; Eduardo CAMPOS ALBERTO ; Shuichi SUZUKI ; Yoshinori SATO ; Akira HOSHIOKA ; Hiroki ABE ; Kimiyuki SAITO ; Toshikazu TSUBAKI ; Mana HARAKI ; Akiko SAWA ; Yoshio NAKAYAMA ; Hiroyuki KOJIMA ; Midori SHIGETA ; Fumiya YAMAIDE ; Yoichi KOHNO ; Naoki SHIMOJO
Asia Pacific Allergy 2017;7(1):10-18
BACKGROUND: Leukotriene receptor antagonists have been used to prevent virus-induced asthma exacerbations in autumn. Its efficacy, however, might differ with age and sex. OBJECTIVE: This study aimed to investigate whether pranlukast added to usual asthma therapy in Japanese children during autumn, season associated with the peak of asthma, reduces asthma exacerbations. It was also evaluated the effect of age and sex on pranlukast's efficacy. METHODS: A total of 121 asthmatic children aged 1 to 14 years were randomly assigned to receive regular pranlukast or not according to sex, and were divided in 2 age groups, 1–5 years and 6–14 years. The primary outcome was total asthma score calculated during 8 weeks by using a sticker calendar related to the days in which a child experienced a worsening of asthma symptoms. This open study lasted 60 days from September 15 to November 14, 2007. RESULTS: Significant differences in pranlukast efficacy were observed between sex and age groups. Boys aged 1 to 5 years had the lower total asthma score at 8 weeks (p = 0.002), and experienced fewer cold episodes (p = 0.007). There were no significant differences between pranlukast and control group in total asthma score at 8 weeks (p = 0.35), and in the days in which a child experienced a worsening of asthma symptoms (p = 0.67). CONCLUSION: There was a substantial benefit of adding pranlukast to usual therapy in asthmatic children, especially in boys aged 1 to 5 years, during autumn season.
Asian Continental Ancestry Group
;
Asthma
;
Child
;
Child, Preschool
;
Humans
;
Leukotriene Antagonists
;
Seasons